Shots: Brian talked about the $17 million in Series A funding led by Blue Ledge Capital including other ventures Brian also spoke about multiple products being developed in Qnovia’s pipeline. The funding will advance its NRT drug candidate through an IND submission in 2023 The interview gives an understanding of how Qnovia is developing innovative…